Home > > > > > Report Detail

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Publisher Name :
Date: 01-Feb-2015
No. of pages: 1325
Inquire Before Buying

The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.

Revised and updated 11th edition, includes:


  • Trends in co-promotion and co-marketing deals

  • Co-promotion and co-marketing agreement structure

  • Co-promotion and co-marketing contract documents

  • Top co-promotion deals by value

  • Top co-marketing deals by value

  • Most active co-promotion dealmakers

  • Most active co-marketing dealmakers


This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.

Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2009 to end of December 2014.

The report provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics includes:


  • Trends in co-promotion and co-marketing dealmaking in the biopharma industry since 2009

  • Analysis of co-promotion and co-marketing deal structure

  • Case studies of real-life co-promotion and co-marketing deals

  • Access to over 800 co-promotion and co-marketing deal records

  • Detailed access to actual co-promotion contract documents

  • The leading co-promotion and co-marketing deals by value since 2009

  • Most active co-promotion and co-marketing dealmakers since 2009

  • The leading co-promotion and co-marketing partnering resources


In Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, the available contracts are listed by:

  • Company A-Z

  • Headline value

  • Stage of development at signing

  • Therapeutic area

  • Technology area


Each deal title links via Weblink to an online version of deal record as found in the Current Agreements deals and alliances database, providing easy access to each deal record on demand.

The Co-promotion and Co-marketing Partnering Terms and Agreements report provides comprehensive access to records for over 700 co-promotion and co-marketing deals. Analyzing actual contract agreements allows assessment of the following:


  • What are the precise co-promotion and co-marketing rights granted or optioned?

  • What is actually granted by the agreement to the partner company?

  • What exclusivity is granted?

  • What is the payment structure for the deal?

  • How aresalesand payments audited?

  • What is the deal term?

  • How are the key terms of the agreement defined?

  • How are IPRs handled and owned?

  • Who is responsible for commercialization?

  • Who is responsible for development, supply, and manufacture?

  • How is confidentiality and publication managed?

  • How are disputes to be resolved?

  • Under what conditions can the deal be terminated?

  • What happens when there is a change of ownership?

  • What sublicensing and subcontracting provisions have been agreed?

  • Which boilerplate clauses does the company insist upon?

  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

  • Which jurisdiction does the company insist upon for agreement law


Benefits

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics provides the reader with the following key benefits:


  • In-depth understanding of co-promotion and co-marketing deal trends since 2009

  • Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies

  • Comprehensive access to over 800 co-promotion and co-marketing deals entered into by the world's biopharma companies, together with contract documents if available

  • Detailed access to actual co-promotion and co-marketing contracts entered into by the leading fifty big pharma and big biotech companies

  • Understand the key deal terms companies have agreed in previous deals

  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

  • Identify leading co-promotion and co-marketing deals by value since 2009

  • Identify the most active co-promotion and co-marketing dealmakers since 2009

  • Full listing of co-promotion and co-marketing deals by company A-Z, headline value, phase of development, deal type, therapy and technology focus

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking
2.1. Introduction
2.2. Difference between co-promotion and co-marketing deals
2.3. Trends in co-promotion deals since 2009
2.4. Trends in co-marketing deals since 2009
2.4.1. When co-marketing can be useful
2.4.2. When co-marketing is the only option
2.5. Pure deals and multi-component deals
2.5.1. Attributes of pure co-promotion deals
2.5.2. Attributes of co-promotion in multi-component deals
2.6. Reasons for including co-promotion options in a deal
2.7. Uptake of co-promotion rights
2.8. Co-promotion rights as bargaining chips
2.9. Aligning partners to make the co-promote work
2.10 The future of co-promotion as part of multicomponent deals

Chapter 3 - Overview of co-promotion deal structure
3.1. Introduction
3.2. Pure versus multi-component co-promotion deals
3.3. Pure co-promotion agreement structure
3.3.1. Example co-promotion agreements
3.3.1.a. Case study 1: Allergan - MAP Pharmaceuticals - January 2011
3.3.1.b. Case study 2: Genzyme - Veracyte - January 2012
3.4. Co-promotion rights as part of a wider alliance agreement
3.4.1. Example co-promotion option clauses
3.4.1.a. Case study 3: Takeda Pharmaceutical- Orexigen Therapeutics- Sep 2010
3.4.1.b. Case study 4: Sanofi-Aventis - Merrimack Pharmaceuticals - Oct 2009
3.4.2. Example co-promotion right clauses
3.4.2.a. Case study 5: Takeda - Orexigen - September 2010
3.4.2.b. Case study 6: Abbvie - Receptos - March 2013
3.5. Embedded co-promotion rights enabling third party engagement
3.5.1. Example co-promotion clauses enabling third party engagement
3.5.1.a. Case study 7: Astellas - Ambit Biosciences - December 2009

Chapter 4 - Overview of co-marketing deal structure
4.1. Introduction
4.2. Co-marketing agreement structure
4.2.1. Example co-marketing agreements
4.2.1.a. Case study 8: AstraZeneca -Ironwood Pharmaceuticals- Oct 2012
4.3. Co-marketing rights as part of a wider alliance agreement
4.3.1. Example co-marketing right clauses
4.3.1.a. Case study 9: Lundbeck - Myriad Genetics - May 2008

Chapter 5 - Leading co-promotion deals
5.1. Introduction
5.2. Top co-promotion deals by value
5.3. Most active co-promotion dealmakers
5.4. Big pharma co-promotion deal activity
5.5. Big biotech co-promotion deal activity

Chapter 6 - Leading co-marketing deals
6.1. Introduction
6.2. Top co-marketing deals by value
6.3. Most active co-marketing dealmakers
6.4. Big pharma co-marketing deal activity

Chapter 7 - Big pharma co-promotion and co-marketing deals
7.1. Introduction
7.2. How to use co-promotion and co-marketing deals
7.3. Big pharma co-promotion and co-marketing agreement listings

Chapter 8 - Co-promotion agreement contracts directory 2009-2014
8.1. Introduction
8.2. Co-promotion partnering deals by company A-Z
8.3. By therapy area
8.4. By stage of development at signing
8.5. By technology area

Chapter 9 - Co-marketing agreement contracts directory 2009-2014
9.1. Introduction
9.2. Company A-Z
9.3. By therapy area
9.4. By stage of development at signing
9.5. By technology type

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Upgrades to subscription access products
Order Form - Reports

Appendices
Appendix A1: Co promotion dealmaking- by companies A-Z
Appendix A2: Co promotion dealmaking- by stage of development
Appendix A3: Co promotion dealmaking- by therapeutic target
Appendix A4: Co promotion dealmaking- by technology type
Appendix B1: Co marketing dealmaking- by companies A-Z
Appendix B2: Co marketing dealmaking- by stage of development
Appendix B3: Co marketing dealmaking- by therapeutic target
Appendix B4: Co marketing dealmaking- by technology type

List of Figures

Figure 1: Definition of co-promotion and co-marketing
Figure 2: Trends in co-promotion deal announcements, 2009-2014
Figure 3: Co-promotion deals signed at each phase of development, 2009-2014
Figure 4: Trends in co-marketing deal announcements, 2009-2014
Figure 5: Co-marketing deals signed at certain phases of development, 2009-2014
Figure 6: Situations where co-marketing can prove useful
Figure 7: Pure versus multi-component co-promotion deal announcements, 2009-2014
Figure 8: Stage of development at which pure and multi-component co-promotion deals are announced 2002-2014
Figure 9: Pure versus multi-component co-marketing deal announcements, 2009-2014
Figure 10: Stage of development at which pure and multi-component co-marketing deals are announced 2002-2014
Figure 11: Key components of a pure co-promotion deal
Figure 12: Key components of a multi-component co-promotion deal
Figure 13: Example deals where co-promotion options have been actively exercised, since 2000
Figure 14: Issues in implementing co-promotion agreements
Figure 15: Co-promotion agreements - what should a contract include?
Figure 16: Components of the co-promotion deal structure
Figure 17: Components of the co-marketing deal structure
Figure 18: Top co-promotion deals by value since 2009
Figure 19: Most active co-promotion dealmakers 2009-2014
Figure 20: Big pharma - top 50 - co-promotion deals 2009 to 2014
Figure 21: Big pharma co-promotion deal frequency - 2009 to 2014
Figure 22: Big biotech - top 50 - co-promotion deals 2009 to 2014
Figure 23: Big biotech co-promotion deal frequency - 2009 to 2014
Figure 24: Top co-marketing deals by value since 2009
Figure 25: Most active co-marketing dealmakers 2009-2014
Figure 26: Big pharma - top 50 - co-marketing deals since 2009
Figure 27: Big pharma co-marketing deal frequency - 2009 to 2014

  • Licensing Terms and Agreements in Pharma, Biotech and Diagnostics
    Published: 01-Feb-2015        Price: US 3495 Onwards        Pages: 1028
    The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of how and why companies enter licensing deals. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you......
  • Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
    Published: 01-Feb-2015        Price: US 1995 Onwards        Pages: 1325
    The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 11th edition, includes: Trends in co-promotion and co-marketing deals Co-promotion and co-marketing agreement structure Co-promotion and co-......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs